Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock

Clinical and Experimental Immunology

Volumn 103, Issue 2, 1996, Pages 233-238

  Jacobs, F ^a   Dubois, C ^a   Carlier, Y ^b   Goldman, M ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Anti CD3 monoclonal antibody; Interferon gamma; Trypanosoma cruzi; Tumour necrosis factor alpha

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHOCK; TRYPANOSOMA CRUZI;

EID: 0030069317     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-632.x     Document Type: Article

References (41)

1. Soong L, Tarleton RL. Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin-2 enhancer. Eur J Immunol 1994; 24:16-23.
2. Harel-Bellan A, Joskowicz M, Fradelizi D, Eisen H. Modification of T cell proliferation and IL-2 production in mice infected with Trypanosoma cruzi. Proc Natl Acad Sci 1983; 80:3466-9.
3. Tarleton RL. Trypanosoma-cruzi induced suppression of IL-2 production. I. Evidence for the presence of IL-2 producing cells. J Immunol 1988; 140:2763-8.
4. Nabors GS, Tarleton RL. Differential control of IFN-γ and IL-2 production during Trypanosoma cruzi infection. J Immunol 1991; 146:3591-8.
5. Reed SG, Nathan CF, Pihl DL, Rodricks P, Shanebeck K, Conlon PJ, Grabstein KH. Recombinant granulocyte-macrophagc colony stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide: comparison to interferon-gamma. J Exp Med 1987; 166:1734-46.
6. Wirth JJ, Kierszenbaum F, Sonnenfeld G, Zlotnik A. Enhancing effects of gamma interferon on phagocytic cell association with and killing of Trypanosoma cruzi. Infect Immun 1985; 49:61-66.
7. McCabe RE, Meagher SG, Mullins BT. Gamma interferon suppresses acute and chronic Trypanosoma cruzi infection in cyclosporin-treated mice. Infect Immun 1991; 59:1633-8.
8. Reed SG. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosnma cruzi infections. J Immunol 1988; 140:4342-7.
9. McCabe RE, Meagher SG, Mullins BT. Endogenous interferon-γ, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi. J Infect Dis 1991; 163:912-5.
10. Torrico F, Heremans H, Rivera MT, Van Marck E, Billiau A, Carlier Y. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 1991; 146:3626-32.
11. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. Eur J Immunol 1992; 22:2501-6.
12. Metz G, Carlier Y, Vray B. Trypanosoma cruzi upregulates nitric oxide release by IFN-γ-preactivated macrophages, limiting cell infection independently of the respiratory burst. Parasite Immunol 1993; 15:693-9.
13. Munoz-Fernandez MA, Fernandez MA, Fresno M. Synergism between tumor necrosis factor α and interferon γ on macrophage activation against intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 1992; 22:301-7.
14. Petray P, Rottenberg ME, Grinstein S, Orn A. Release of nitric oxide during the experimental infection with Trypanosoma cruzi. Parasite Immunol 1994; 16:193-9.
15. Vespa GNR, Cunha FQ, Silva JS. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 1994; 62:5177-82.
16. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 1987; 84:1374-8.
17. Alegre M, Vandenabeele P, Flamand V et al. Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur J Immunol 1990; 20:707-10.
18. Ferran C, Sheehan K, Dy M et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol 1990; 20:509-15.
19. Matthys P, Dillen C, Proost P, Heremans H, Van Damme J, Billiau A. Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-γ or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels. Eur J Immunol 1993; 23:2209-16.
20. Carlier Y, Rivera MT, Truyens C, Puissant F, Milaire J. Interactions between chronic murine Trypanosoma cruzi infection and pregnancy: foetal growth retardation. Am J Trop Med Hyg 1987; 37:534-40.
21. Dialynas D, Wilde D, Marrack P et al. Characterization of the murine antigenic determinant designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol Rev 1983; 74:29-56.
22. Pierres M, Goridis C, Goldstein P. Inhibition of murine T-cell mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating lymphoid cell surface polypeptides of 94,000 and 180,000 molecular weight. Eur J Immunol 1982; 12:60-69.
23. Havell E. Purification and further characterization of an antimurine interferon-γ monoclonal neutralizing antibody. J Interferon Res 1986; 6:489-97.
24. Donckier V, Flament V, Gérard C et al. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10. Transplantation 1994; 57:1436-9.
25. 15N]nitrate in biological fluids. Analyt Biochem 1982; 126:131-8.
26. Florquin S, Amraoui Z, Dubois C, Decuyper J, Goldman M. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med 1994; 180:1153-8.
27. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info version 5: a word processing, database, and statistics program for epidemiology on microcomputer. Stone Mountain, Georgia: USD Incorp., 1990.
28. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-12.
29. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90:1718-25.
30. Rottenberg ME, Bakhiet M, Olsson T, Kristensson K, Mak T, Wigzell H, Örn A. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun 1993; 61:5129-33.
31. 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 1992; 356:338-40.
32. Rottenberg ME, Sunnemark D, Leandersson T, Örn A. Organ-specific regulation of interferon-γ, interleukin-2 and interleukin-2 receptor during murine infection with Trypanosoma cruzi. Scand J Immun 1993; 37:559-68.
33. Vandekerckhove F, Darji A, Rivera MT, Carlier Y, Vray B, Billiau A, Dc Baetselier P. Modulation of T-cell responsiveness during Trypanosoma cruzi infection: analysis in different lymphoid compartments. Parasite Immunol 1994; 16:77-85.
34. Kast WM, Bluestone JA, Heemskerck MHM, Spaargaren J, Voordouw AC, Ellenborn JDI, Melief CJM. Treatment with monoclonal anti-CD3 antibody protects against lethal Sendai virus infection by induction of natural killer cells. J Immunol 1990; 145:2254-9.
35. Nakane A, Okamoto M, Asano M, Kohanawa M, Minagawa T. An anti-CD3 monoclonal antibody protects mice against a lethal infection with Listeria monocytogenes through induction of endogenous cytokines. Infect Immun 1993; 61:2786-92.
36. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57.
37. van der Poll T, Büller HR, ten Cate H et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322:1622-7.
38. Zuckerman SH, Suprenant YM. Induction of endothelial cell/ macrophage procoagulant activity: synergistic stimulation by gamma interferon and granulocyte macrophage colony stimulating factor. Thromb Haemost 1989; 61:178-82.
39. Kirchhoff LV. American trypanosomiasis (Chagas' disease) - a tropical disease now in the United States. New Engl J Med 1993; 329:639-44.
40. Abramowicz D, Schandené L, Goldman M et al. Release of tumor necrosis factor, interleukin-2 and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 1989; 47:606-8.
41. Chatenoud L, Ferran C, Reuter A et al. Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma. N Engl J Med 1989; 320:1420-1.